|Awarded On||August 16, 2023|
|Title||"Click" Assembled Colloidal Molecules with Tunable Plasmon Bands as Novel Agents for Photothermal Tumor Therapy|
|Award Mechanism||TREC: Pilot Study Award|
|Institution/Organization||Texas Tech University Health Sciences Center|
|Principal Investigator/Program Director||Hongjun Liang|
|Cancer Sites||Breast, Head and Neck, Lymphoma|
*Pending contract negotiation
If you hold your hand toward the Sun, you will find your fingers are glowing red owing to the preferential penetration of red and near infrared (NIR) light. The totally benign tissue-penetrating NIR light can be absorbed by tumor-homing antennas and converted into heat to kill cancer cells. This new treatment option is called photothermal tumor therapy (PTT). PTT is widely regarded as a promising alternative to chemotherapy that has long been plagued by problems such as the toxic side-effects of the chemotherapy agents and the difficulty to selectively deliver them to the tumor sites. Many antennas including organic dyes, polymers, and inorganic nanoparticles (1 nanometer is one millionth of...